Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 4 (2007), Issue 9 (September)

1. Decitabine up-regulates S100A2 expression and synergizes with IFN-gamma to kill uveal melanoma cells.
   Clin Cancer Res, 13(17): 5219-25. [Abstract] [Full-text]
2. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
   Clin Cancer Res, 13(17): 5010-9. [Abstract] [Full-text]
3. Mexoryl: a review of an ultraviolet a filter.
   Plast Reconstr Surg, 120(4): 1071-5. [Abstract] [Full-text]
4. Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases.
   Cancer, 110(6): 1329-37. [Abstract] [Full-text]
5. Cellular co-localization of intron-4 containing mRNA and HLA-G soluble protein in melanoma analyzed by fluorescence in situ hybridization.
   J Immunol Methods, 326(1): 54-62. [Abstract] [Full-text]
6. Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma.
   J Cancer Res Clin Oncol, 133(11): 897-901. [Abstract] [Full-text]
7. Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients.
   J Cancer Res Clin Oncol, 133(11): 859-66. [Abstract] [Full-text]
8. Plaque radiotherapy for choroidal melanoma encircling the optic disc (circumpapillary choroidal melanoma).
   Arch Ophthalmol, 125(9): 1202-9. [Abstract] [Full-text]
9. Differential locomotion of long- and short-term IL-2-activated murine natural killer cells in a model matrix environment.
   Scand J Immunol, 66(4): 402-9. [Abstract] [Full-text]
10. Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice.
    J Invest Dermatol, 127(10): 2411-7. [Abstract] [Full-text]
11. Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model.
    J Invest Dermatol, 127(10): 2399-410. [Abstract] [Full-text]
12. Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb.
    Clin Immunol, 125(1): 76-87. [Abstract] [Full-text]
13. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma.
    J Am Acad Dermatol, 57(4): 659-64. [Abstract] [Full-text]
14. Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions.
    J Am Acad Dermatol, 57(4): 555-72; quiz 573-6. [Abstract] [Full-text]
15. Characterization of benign and malignant melanocytic skin lesions using optical coherence tomography in vivo.
    J Am Acad Dermatol, 57(4): 629-37. [Abstract] [Full-text]
16. Filamin A negatively regulates the transcriptional activity of p73alpha in the cytoplasm.
    Biochem Biophys Res Commun, 362(4): 1101-6. [Abstract] [Full-text]
17. The evolution of the management of regional lymph nodes in melanoma.
    J Surg Oncol, 96(4): 316-21. [Abstract] [Full-text]
18. Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response.
    Int J Cancer, 121(9): 2023-30. [Abstract] [Full-text]
19. Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors.
    Hum Pathol, 38(10): 1516-25. [Abstract] [Full-text]
20. Reduced expression of autotaxin predicts survival in uveal melanoma.
    Br J Ophthalmol, 91(10): 1385-92. [Abstract] [Full-text]
21. Fundus autofluorescence of choroidal nevus and melanoma.
    Br J Ophthalmol, 91(10): 1299-302. [Abstract] [Full-text]
22. Immediate, optimal reconstruction of facial lentigo maligna and melanoma following total peripheral margin control.
    Plast Reconstr Surg, 120(5): 1249-55. [Abstract] [Full-text]
23. Promoter methylation status of multiple genes in uveal melanoma.
    Invest Ophthalmol Vis Sci, 48(10): 4403-6. [Abstract] [Full-text]
24. Using the direct-injection model of early uveal melanoma hepatic metastasis to identify TPS as a potentially useful serum biomarker.
    Invest Ophthalmol Vis Sci, 48(10): 4399-402. [Abstract] [Full-text]

© 2004-2010 Melanoma Research Today. All Rights Reserved.